Author

Petra Acha

OpenAlex ID: A5047372136

Multicenter phase Ib trial in the U.S. of salvage CT041 CLDN18.2-specific chimeric antigen receptor T-cell therapy for patients with advanced gastric and pancreatic adenocarcinoma.

2022 · Gregory P. Botta, Carlos Roberto Becerra, et al. · Journal of Clinical Oncology · 31

Works count: 1

Citation count: 31

H-index: 1

I10-index: 1